Renal Cancer - Results from #2680

The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. July 6, 2020

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. July 6, 2020

Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers. July 3, 2020

Resveratrol Inhibition of Renal Cancer Stem Cell Characteristics and Modulation of the Sonic Hedgehog Pathway. July 3, 2020

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. July 3, 2020

TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma. July 2, 2020

Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma. July 1, 2020

To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma. July 1, 2020

Trigonometric Concept of Fluoroscopy-Guided Percutaneous Renal Access June 30, 2020

Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. June 30, 2020

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score. June 30, 2020

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events. June 29, 2020

Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer. June 29, 2020

Results of surgical treatment of inferior vena cava tumor thrombi in renal cell carcinoma. June 26, 2020

Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report. June 26, 2020

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma. June 25, 2020

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma. June 25, 2020

C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma. June 24, 2020

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. June 24, 2020

COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer. June 24, 2020

Page 135 of 456